The Health and Human Services Department is considering cuts to HIV prevention funding, according to The Wall Street Journal.
1 天
Investor's Business Daily on MSNGilead Dives As HHS Reportedly Mulls Cutting HIV Prevention FundingGilead stock tumbled Wednesday on reports HHS could slash federal funding for HIV prevention, a staple in Gilead Sciences' ...
1 天
Stocktwits on MSNGilead Stock Wobbles On Federal HIV Funding Cut Buzz, But Retail And Analysts Stay UnfazedShares of Gilead Sciences, Inc. dropped nearly 2.5% on Wednesday and extended losses after hours following a report that the ...
Shares of Gilead Sciences (NASDAQ: NASDAQ:GILD) fell 3.4% following a recent Wall Street Journal report indicating that the ...
Investing.com -- Gilead Sciences shares dropped more than 3% Wednesday following a Wall Street Journal report that the Health ...
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...
This potential policy shift is raising concerns about the impact on Gilead Sciences, a major player in HIV treatment and prevention. The Wall Street Journal outlined that the proposed funding cuts ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果